Neuronetics (STIM) EBITDA Margin (2017 - 2026)
Neuronetics (STIM) posted quarterly EBITDA Margin of 26.11% for Q1 2026, up 834.0% year-over-year from 2.8% in Q1 2025, and down 116.28% quarter-over-quarter from 12.07% in Q4 2025.
Neuronetics (STIM) EBITDA Margin (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported EBITDA Margin for 10 consecutive years, with 26.11% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 834.0% year-over-year to 26.11%; the TTM figure through Mar 2026 stood at 19.4% (up 2389.0% YoY), while the FY2025 annual figure was 21.08%, up 2508.0% from the prior year.
- EBITDA Margin declined to 26.11% in Q1 2026 per STIM's latest filing, from 12.07% in the prior quarter.
- Across five years, EBITDA Margin topped out at 12.07% in Q4 2025 and bottomed at 71.47% in Q1 2022.
- Historically, EBITDA Margin has averaged 40.78% across 5 years, with a median of 41.73% in 2023.
- Annual changes were most pronounced in 2024 — EBITDA Margin sank 2921 bps — and 2025, when it soared 3893 bps.
- Neuronetics' EBITDA Margin stood at 42.46% in 2022, then surged by 49 bps to 21.79% in 2023, then sank by 134 bps to 51.0% in 2024, then surged by 76 bps to 12.07% in 2025, then plunged by 116 bps to 26.11% in 2026.
- Business Quant data shows STIM's EBITDA Margin at 26.11% in Q1 2026, 12.07% in Q4 2025, and 19.63% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | Neuronetics | 225.97 Mn | 206.54 Mn | 21.22 Mn | -3.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.61% |
| Mar 31, 2026 | -26.11% |
| Dec 31, 2025 | -12.07% |
| Sep 30, 2025 | -19.63% |
| Jun 30, 2025 | -21.15% |
| Mar 31, 2025 | -34.45% |
| Dec 31, 2024 | -51.00% |
| Sep 30, 2024 | -41.71% |
| Jun 30, 2024 | -51.71% |
| Mar 31, 2024 | -39.38% |
| Dec 31, 2023 | -21.79% |
| Sep 30, 2023 | -49.60% |
| Jun 30, 2023 | -41.73% |
| Mar 31, 2023 | -63.75% |
| Dec 31, 2022 | -42.46% |
| Sep 30, 2022 | -45.18% |
| Jun 30, 2022 | -59.99% |
| Mar 31, 2022 | -71.47% |
| Dec 31, 2021 | -45.99% |
| Sep 30, 2021 | -52.05% |